Ramer Â· Alavi Nuclear Medicine Technology

More documents

Recommendations

Info

2 Radioactivity, Radiopharmacy, and Quality Assurance 1344) A dose of 99m Tc DMSA is prepared and calibrated tocontain 5.0 mCi at 8:00 a.m. The patient arrives late at10:00 a.m. Without using any tables of decay factors,determine what activity will remain in the dose atthat time.a. 3.40 mCib. 3.54 mCic. 3.62 mCid. 3.97 mCi45) A MAA kit contains 950,000 particles per ml. Theactivity in the kit is 50 mCi of 99m Tc in 5 ml. If a 4 mCidose is drawn up, how many particles will be in the dose?a. 76,000b. 380,000c. 410,000d. 450,00046) What will happen to the dose in question 47 if it sits forone hour?a. the number of particles per mCi will increaseb. the number of particles per mCi will decreasec. the number of particles per mCi will remainunchanged47) A volume of 5 ml containing 40 mCi of 99m Tc is addedto an MAA kit with an average of 3,000,000 particles.What volume of the reconstituted kit should be withdrawnto prepare a dose for a patient with severepulmonary hypertension?a. 0.25 mlb. 0.40 mlc. 0.45 mld. 0.50 ml
Page 5 and 6: Table of Contents1 Introduction . .
Page 7 and 8: 21 IntroductionIn response to all o
Page 9 and 10: 42 Radioactivity, Radiopharmacy, an
Page 11 and 12: 62 Radioactivity, Radiopharmacy, an
Page 13: 82 Radioactivity, Radiopharmacy, an
Page 17: 122 Radioactivity, Radiopharmacy, a
Page 22 and 23: 2 Radioactivity, Radiopharmacy, and
Page 24 and 25: 2 Radioactivity, Radiopharmacy, and
Page 26 and 27: 3 Radiation Safety 215) The inverse
Page 28 and 29: 14) The philosophy of the ALARA pro
Page 30 and 31: 3 Radiation Safety 2522) A room con
Page 32 and 33: 3 Radiation Safety 2729) Tools for
Page 34 and 35: 3 Radiation Safety 2937) Which of t
Page 36 and 37: 4 Instrumentation and Quality Assur
Page 40 and 41: 20) Which of the following degrade
Page 52 and 53: 5 Image Presentation and Computers1
Page 54 and 55: 5 Image Presentation and Computers
Page 56 and 57: 21) PET images are reconstructed us
Page 58 and 59: 6 Skeletal System Scintigraphy 535)
Page 60 and 61: 6 Skeletal System Scintigraphy 5514
Page 68 and 69:
7 Central Nervous System Scintigrap
Page 70 and 71:
Page 72 and 73:
Page 74 and 75:
8 Cardiovascular System Scintigraph
Page 76 and 77:
Page 78 and 79:
Page 80 and 81:
Page 82 and 83:
Page 84 and 85:
Page 86 and 87:
Page 88 and 89:
Page 90 and 91:
Page 92 and 93:
9 Respiratory System Scintigraphy 8
Page 94 and 95:
Page 96 and 97:
Page 98 and 99:
Page 100 and 101:
Page 102 and 103:
Figure 10.110 Gastrointestinal Trac
Page 104 and 105:
10 Gastrointestinal Tract Scintigra
Page 106 and 107:
Page 108 and 109:
Page 110 and 111:
36) Symptoms of cholecystitis may i
Page 112 and 113:
11 Genitourinary System Scintigraph
Page 114 and 115:
Page 116 and 117:
Page 118 and 119:
Page 120 and 121:
Page 122 and 123:
12 Neoplasm and Infection Scintigra
Page 124 and 125:
Page 126 and 127:
19) Hodgkin’s disease is a type o
Page 128 and 129:
Page 130 and 131:
Page 132 and 133:
13 Thyroid, Parathyroid, and Saliva
Page 134 and 135:
Page 136 and 137:
Page 138 and 139:
Page 140 and 141:
Page 142 and 143:
14 Non-Imaging Procedures and Radio
Page 144 and 145:
Page 146 and 147:
Page 148 and 149:
Page 150 and 151:
Page 152 and 153:
5) NPO means:a. no preparation for
Page 154 and 155:
15 Patient Care 14914) If a patient
Page 156 and 157:
15 Patient Care 15122) Which of the
Page 158 and 159:
16 Mock Examination 1534) A Hine-Du
Page 160 and 161:
16 Mock Examination 15512) All of t
Page 162 and 163:
16 Mock Examination 15721) If 450 m
Page 164 and 165:
16 Mock Examination 15925) Calculat
Page 166 and 167:
16 Mock Examination 16133) A patien
Page 168 and 169:
16 Mock Examination 163Figure 16.34
Page 170 and 171:
16 Mock Examination 16548) For a pa
Page 172 and 173:
16 Mock Examination 16757) Given th
Page 174 and 175:
16 Mock Examination 16966) If a via
Page 176 and 177:
16 Mock Examination 17175) If 800 m
Page 178 and 179:
16 Mock Examination 17383) If the H
Page 180 and 181:
1.b2.c3.b4.b5.d6.a7.b8.b9.c10.c11.b
Page 182 and 183:
Appendix 1771.b2.b3.b4.a5.b6.c7.d8.
Page 184:
Appendix 1791.d2.a3.b4.b5.b6.c7.c8.
show all

Ramer Â· Alavi Nuclear Medicine Technology

Create successful ePaper yourself

Delete template?

Save as template?